Skip to content

Medical-device intelligence

Phadia US Inc: FDA clearances and recalls

Research Phadia US Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

21 clearance records and 10 recall records in the covered releases, across 1 source company names and 17 product codes. Dated history runs from Dec 26, 2006 to May 1, 2023.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

31 matching records
Device / recordCompany in FDA recordSourceSource date
EliA GliadinDP IgG Well in the Phadia 2500EE instrument (Material Number 12410002) EliA GliadinDP IgG is intended for the in vitro semi-quantitat…Z-2040-2023 · MSTPhadia US IncRecallJun 30, 2023FDA classification date
Phadia 2500EE instrument -Intended for the in vitro semi-quantitative measurement of IgG antibodies directed to gliadin in human serum or plasma …Z-2041-2023 · MSTPhadia US IncRecallJun 30, 2023FDA classification date
EliA dsDNA Well - Product Usage: intended for the In-Vitro quantitative measurement of IgG antibodies directed to dsDNA in human serum and plasma…Z-1107-2021 · LSWPhadia US IncRecallFeb 11, 2021FDA classification date
ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of …Z-1312-2018 · DHBPhadia US IncRecallApr 5, 2018FDA record creation date
ImmunoCAP Allergen c6, Amoxicilloyl ( Article number 14-4451-016). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement …Z-1313-2018 · DHBPhadia US IncRecallApr 5, 2018FDA record creation date
Phadia 1000 Instrument, Article Number 12-3800-01.Z-0387-2018 · DHBPhadia US IncRecallJan 18, 2018FDA record creation date
EliA Sample Diluent, Article number, 83-1023-01Z-1253-2017 · NHXPhadia US IncRecallFeb 24, 2017FDA classification date
ELIA M2; IMMUNOASSAY, POSITIVE CONTROL 100, POSITIVE CONTROL 250K141375 · DBMPhadia US, Inc.510(k)Feb 13, 2015FDA decision date
Phadia 1000 Instrument (introduced as UniCAP 1000), Article number: 12-3800-01 (All instrument software versions since launch in 2003); Multiple …Z-0947-2015 · DHBPhadia US IncRecallJan 12, 2015FDA classification date
ELIA PR3S IMMUNOASSAY, ELIA MPOS IMMUNOASSAY, ELIA GBM IMMUNOASSAY, ELIA ANCA/GBM POSITIVE CONTROL 100, ELIA ANCA/GBM POK140225 · MOBPhadia US, Inc.510(k)Oct 27, 2014FDA decision date
EIA SMDP IMMUNOASSAYK132631 · LKPPhadia US, Inc.510(k)Aug 29, 2014FDA decision date
ELIA(TM) CARDIOLIPIN IGA IMMUNOASSAYK131821 · MIDPhadia US, Inc.510(k)Dec 23, 2013FDA decision date
AUTOMATED IN VITRO QUANTITATIVE ASSAY FOR THE MEASUREMENT OF ALLERGEN SPECIFIC IGE ANTIBODIESK122197 · DHBPhadia US, Inc.510(k)Aug 28, 2013FDA decision date
IMMUNOCAP ALLERGEN COMPONENTS BUNDLEK113841 · DHBPhadia US, Inc.510(k)Sep 13, 2012FDA decision date
PHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies)Z-2285-2012 · MIDPhadia US IncRecallAug 28, 2012FDA classification date
ELIA B2-GLYCOPROTEIN I IGA IMMUNOASSAYK112414 · MSVPhadia US, Inc.510(k)Jun 22, 2012FDA decision date
ImmunoCAP Allergen Ri206, Cockroach American, Periplaneta americana It is an analyte specific reagent and no intended use, however, it is typica…Z-1055-2012 · MVUPhadia US IncRecallFeb 17, 2012FDA classification date
IMMUNOCAP SPECIFIC IGE ALLERGEN BUNDLE, 12 ALLERGEN COMPONENTSK111919 · DHBPhadia US, Inc.510(k)Dec 22, 2011FDA decision date
RHEUMATOID FACTOR IMMUNOLOGICAL TEST SYSTEMK102673 · DHRPhadia US, Inc.510(k)Sep 30, 2011FDA decision date
ELIA GLIADIN DP IGA IMMUNOASSAY AND ELIA GLIADIN DP IGG IMMUNOASSAY, MODELS 14-5538-01, 14-5539-01K093459 · MSTPhadia US, Inc.510(k)Aug 13, 2010FDA decision date
CARDIOLIPIN AUTOANTIBODY IMMUNOLOGICAL TEST SYSTEMK091845 · MIDPhadia US, Inc.510(k)Jun 7, 2010FDA decision date
IMMUNOCAP RAPID READER, MODEL 12-3600-10K092978 · DHBPhadia US, Inc.510(k)Jan 19, 2010FDA decision date
ELIA RNP70 IMMUNOASSAY, ELIA SCI-70 IMMUNOASSAY AND ELIA JO-1 IMMUNOASSAY, MODELS 14-5511-01, 14-5506-01 AND 14-5507-01K083117 · LKOPhadia US, Inc.510(k)May 28, 2009FDA decision date
ELIA CENP IMMUNOASSAY, ELIA U1RNP IMMUNOASSAY, ELIA SM IMMUNOASSAY, ELIA RO IMMUNOASSAYK082759 · LKJPhadia US, Inc.510(k)Apr 10, 2009FDA decision date
VARELISA RECOMBI ANA SCREEN, MODEL 12 596K083188 · LJMPhadia US, Inc.510(k)Mar 13, 2009FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗